{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:49:47Z","timestamp":1789904987918,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jhep.2016.05.027","type":"journal-article","created":{"date-parts":[[2016,5,28]],"date-time":"2016-05-28T21:06:35Z","timestamp":1464469595000},"page":"692-699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":277,"title":["Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension"],"prefix":"10.1016","volume":"65","author":[{"given":"Mattias","family":"Mandorfer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Kozbial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Schwabl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa","family":"Freissmuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9my","family":"Schwarzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Chromy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert Friedrich","family":"St\u00e4ttermayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Reiberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Beinhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Sieghart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Trauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnulf","family":"Ferlitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ferenci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Peck-Radosavljevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2016.05.027_b0005","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.cld.2014.07.002","article-title":"Measurement of portal pressure","volume":"18","author":"Abraldes","year":"2014","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2016.05.027_b0010","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4254\/wjh.v7.i4.688","article-title":"Cirrhosis and portal hypertension: The importance of risk stratification, the role of hepatic venous pressure gradient measurement","volume":"7","author":"La Mura","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jhep.2016.05.027_b0015","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.05.027_b0020","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1111\/j.1572-0241.2006.00743.x","article-title":"Antiviral therapy decreases hepatic venous pressure gradient in patients with chronic hepatitis C and advanced fibrosis","volume":"101","author":"Rincon","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2016.05.027_b0025","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.cgh.2007.02.022","article-title":"Effect of sustained viral response on hepatic venous pressure gradient in hepatitis C-related cirrhosis","volume":"5","author":"Roberts","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2016.05.027_b0030","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3851\/IMP2349","article-title":"A prospective evaluation of pulmonary, systemic and hepatic haemodynamics in HIV-HCV-coinfected patients before and after antiviral therapy with pegylated interferon and ribavirin","volume":"17","author":"Reiberger","year":"2012","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jhep.2016.05.027_b0035","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.cgh.2011.03.002","article-title":"Portal pressure predicts outcome and safety of antiviral therapy in cirrhotic patients with hepatitis C virus infection","volume":"9","author":"Reiberger","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2016.05.027_b0040","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/j.gastro.2014.03.051","article-title":"Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis","volume":"147","author":"Hezode","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.05.027_b0045","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jhep.2015.06.003","article-title":"HCV targeting of patients with cirrhosis","volume":"63","author":"Ferenci","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.05.027_b0050","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.gastro.2015.05.010","article-title":"Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease","volume":"149","author":"Charlton","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2016.05.027_b0055","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/apt.13315","article-title":"Interferon-free regimens for chronic hepatitis C overcome the effects of portal hypertension on virologic responses","volume":"42","author":"Mandorfer","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2016.05.027_b0060","doi-asserted-by":"crossref","first-page":"S269","DOI":"10.1016\/S0168-8278(15)30167-7","article-title":"LP13 Effect of long term viral suppression with sofosbuvir + ribavirin on hepatic venous pressure gradient in HCV-infected patients with cirrhosis and portal hypertension","volume":"62","author":"Everson","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.05.027_b0065","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/apt.13343","article-title":"Improvement of liver function parameters in advanced HCV-associated liver cirrhosis by IFN-free antiviral therapies","volume":"42","author":"Deterding","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.jhep.2016.05.027_b0070","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(16)00052-9","article-title":"Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial","volume":"16","author":"Manns","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhep.2016.05.027_b0075","doi-asserted-by":"crossref","first-page":"S269","DOI":"10.1016\/S0168-8278(15)30167-7","article-title":"LP13 Effect of long term viral suppression with sofosbuvir + ribavirin on hepatic venous pressure gradient in HCV-infected patients with cirrhosis and portal hypertension","volume":"62","author":"Afdhal","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.05.027_b0080","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1111\/liv.12783","article-title":"Evaluation of a new balloon occlusion catheter specifically designed for measurement of hepatic venous pressure gradient","volume":"35","author":"Ferlitsch","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2016.05.027_b0085","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00535-011-0517-4","article-title":"Non-selective beta-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis","volume":"47","author":"Reiberger","year":"2011","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jhep.2016.05.027_b0090","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/liv.12623","article-title":"New reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertension","volume":"35","author":"Schwabl","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2016.05.027_b0095","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00535-010-0360-z","article-title":"Prognostic value of a single HVPG measurement and Doppler-ultrasound evaluation in patients with cirrhosis and portal hypertension","volume":"46","author":"Berzigotti","year":"2011","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jhep.2016.05.027_b0100","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-0035-1550056","article-title":"Liver fibrosis in the Post-HCV Era","volume":"35","author":"Pinzani","year":"2015","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2016.05.027_b0105","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s12072-015-9691-4","article-title":"Advances in the management of HIV\/HCV coinfection","volume":"10","author":"Mandorfer","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2016.05.027_b0110","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.cgh.2015.04.013","article-title":"Association between severe portal hypertension and risk of liver decompensation in patients with hepatitis C, regardless of response to antiviral therapy","volume":"13","author":"Lens","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2016.05.027_b0115","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/hep.28470","article-title":"Variceal hemorrhage in a patient with HCV cirrhosis in whom liver synthetic function had normalized after viral elimination","volume":"63","author":"Sack","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.05.027_b0120","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/hep.28264","article-title":"Development of hyperdynamic circulation and response to beta-blockers in compensated cirrhosis with portal hypertension","volume":"63","author":"Villanueva","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.05.027_b0125","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jhep.2009.01.014","article-title":"Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis","volume":"50","author":"Ripoll","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.05.027_b0130","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/apt.13479","article-title":"Letter: can persisting liver stiffness indicate increased risk of HCC, after successful anti-HCV therapy?","volume":"43","author":"Karlas","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2016.05.027_b0135","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/apt.13494","article-title":"Letter: can persisting liver stiffness indicate increased risk for HCC, after successful anti-HCV therapy? \u2013 Authors\u2019 reply","volume":"43","author":"Mandorfer","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2016.05.027_b0140","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1016\/S0168-8278(16)00195-1","article-title":"LBP518 HCV eradication results in reduction of hepatic venous pressure gradient 48 weeks after end of treatment; final results of the study of sofosbuvir plus ribavirin in patients with cirrhosis and portal hypertension","volume":"64","author":"Afdhal","year":"2016","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2016.05.027_b0145","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/jgh.13252","article-title":"Improvement of platelets after SVR among patients with chronic HCV infection and advanced hepatic fibrosis","volume":"31","author":"van der Meer","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2016.05.027_b0150","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jhep.2011.07.005","article-title":"Non invasive evaluation of portal hypertension using transient elastography","volume":"56","author":"Castera","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.05.027_b0155","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/hep.21665","article-title":"Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis","volume":"45","author":"Vizzutti","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.05.027_b0160","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jhep.2011.10.007","article-title":"Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe","volume":"56","author":"Myers","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.05.027_b0165","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jhep.2011.10.017","article-title":"Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan(R)","volume":"56","author":"de Ledinghen","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2016.05.027_b0170","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1148\/radiol.13122208","article-title":"Liver fibrosis: noninvasive assessment with acoustic radiation force impulse elastography\u2013comparison with FibroScan M and XL probes and FibroTest in patients with chronic liver disease","volume":"269","author":"Cassinotto","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2016.05.027_b0175","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1016\/S0168-8278(16)01633-0","article-title":"GS02 Five-year on-treatment systematically monitoring of dynamic changes of liver stiffness measurement with transient elastography compared with paired liver biopsies in a randomized controlled trial in chronic hepatitis B patients","volume":"64","author":"Sun","year":"2016","journal-title":"J Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827816302380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827816302380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T16:39:19Z","timestamp":1530117559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827816302380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0168827816302380"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2016.05.027","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2016.05.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}